Načítá se...
IMMU-34. A BALANCED TRYPTOPHAN DIET LEADS TO MAXIMAL IMMUNOTHERAPEUTIC EFFICACY IN GLIOBLASTOMA MODELS
INTRODUCTION: Immunotherapy has failed to improve glioblastoma (GBM) patient survival in all Phase III clinical trials to-date. A potential mechanism contributing to treatment failure, is based on our recent work showing that, GBM-infiltrating T cells directly increase the intratumoral expression of...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216321/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.537 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|